1. Analyst View
2. Research Methodology
3. US Clinical Laboratory Testing Industry
3.1 Current and Future Market Analysis to 2015
3.2 Market Division by Type of Tests
3.3 Market Division by Type of Lab
4. Consolidation: Picking up Pace in Laboratory Testing
5. Regulatory Framework
5.1 Role of CLIA
5.2 Payment Mechanism
5.3 Drug Testing
5.4 Health Insurance Portability and Accountability Act of 1996 (HIPAA)
5.5 Laboratory Developed Tests (LDTs)
6. Competitive Landscape
6.1 Quest Diagnostics
6.1.1 Business Overview
6.1.2 Key Products and Services
6.1.3 Financial Overview
6.1.4 M&A Activity
6.1.5 Strengths and Weaknesses
6.2 Laboratory Corporation of America (LabCorp)
6.2.1 Business Overview
6.2.2 Key Products and Services
6.2.3 Financial Overview
6.2.4 M&A Activity
6.2.5 Strengths and Weaknesses
6.3 Bio-Reference Laboratories
6.3.1 Business Overview
6.3.2 Key Products and Services
6.3.3 Financial Overview
6.3.4 M&A Activity
6.3.5 Strengths and Weaknesses
6.4 Sonic Healthcare USA
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 M&A Activity
6.4.4 Strengths and Weaknesses
6.5 ARUP Laboratories
6.5.1 Business Overview
6.5.2 Key Products and Services
6.5.3 Strengths and Weaknesses